FDA Expands Endometrial Cancer Indication for Dostarlimab-gxly with Chemotherapy Uterine 4 Mins Read22 On August 1, 2024, the U.S. Food and Drug Administration (FDA) approved an expanded indication for dostarlimab-gxly (Jemperli), in combination…
ASCO 2024 Top 3 Practice Changing Head & Neck Cancer Studies Head and Neck 4 Mins Read17 Introduction ASCO 2024 Head & Neck Cancer developments brought forth several groundbreaking studies in the field of head and neck…
